296P Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis

Authors

Soon Khai Low, Rochester Regional HealthFollow
Zauraiz Anjum, Rochester Regional HealthFollow
Utsav Joshi, Rochester Regional HealthFollow
Amir Mahmoud, Rochester Regional HealthFollow
Peter A. Kouides, Rochester Regional HealthFollow

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Annals of Oncology

Conference Name

ESMO Congress

Conference Date

2022-09-09 - 2022-09-13

First Page

S674

DOI

10.1016/j.annonc.2022.07.430

Volume

33

Issue

Supplement 7

Publication Date

9-2022

Recommended Citation

Low, S., Anjum, Z., Joshi, U., Mahmoud, A., & Kouides, P. A. (2022). 296P Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis. Annals of Oncology, 33 (Supplement 7), S674. https://doi.org/10.1016/j.annonc.2022.07.430